HM Payson & Co’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q3 | $12.1M | Sell |
|
|||||
2025
Q2 | $12.1M | Sell |
|
|||||
2025
Q1 | $13.3M | Sell |
|
|||||
2024
Q4 | $15M | Sell |
|
|||||
2024
Q3 | $18.4M | Sell |
|
|||||
2024
Q2 | $18.4M | Buy |
|
|||||
2024
Q1 | $17.7M | Sell |
|
|||||
2023
Q4 | $20.7M | Sell |
|
|||||
2023
Q3 | $27.1M | Sell |
|
|||||
2023
Q2 | $32.7M | Sell |
|
|||||
2023
Q1 | $67.8M | Sell |
|
|||||
2022
Q4 | $96.4M | Buy |
|
|||||
2022
Q3 | $80.7M | Buy |
|
|||||
2022
Q2 | $95.4M | Buy |
|
|||||
2022
Q1 | $90.1M | Buy |
|
|||||
2021
Q4 | $99M | Buy |
|
|||||
2021
Q3 | $70.4M | Buy |
|
|||||
2021
Q2 | $63.8M | Buy |
|
|||||
2021
Q1 | $58.8M | Sell |
|
|||||
2020
Q4 | $60.4M | Sell |
|
|||||
2020
Q3 | $59.9M | Buy |
|
|||||
2020
Q2 | $50.9M | Buy |
|
|||||
2020
Q1 | $50.2M | Sell |
|
|||||
2019
Q4 | $64M | Buy |
|
|||||
2019
Q3 | $57.5M | Buy |
|
|||||
2019
Q2 | $65.4M | Buy |
|
|||||
2019
Q1 | $63.8M | Buy |
|
|||||
2018
Q4 | $819K | Sell |
|
|||||
2018
Q3 | $55.6M | Sell |
|
|||||
2018
Q2 | $54M | Buy |
|
|||||
2018
Q1 | $52.8M | Sell |
|
|||||
2017
Q4 | $54.2M | Buy |
|
|||||
2017
Q3 | $53.4M | Sell |
|
|||||
2017
Q2 | $50.6M | Sell |
|
|||||
2017
Q1 | $51.5M | Buy |
|
|||||
2016
Q4 | $47.9M | Buy |
|
|||||
2016
Q3 | $48.2M | Buy |
|
|||||
2016
Q2 | $49.1M | Buy |
|
|||||
2016
Q1 | $40.9M | Buy |
|
|||||
2015
Q4 | $43.7M | Buy |
|
|||||
2015
Q3 | $39.4M | Buy |
|
|||||
2015
Q2 | $41.4M | Buy |
|
|||||
2015
Q1 | $42.9M | Sell |
|
|||||
2014
Q4 | $40.1M | Sell |
|
|||||
2014
Q3 | $38.1M | Buy |
|
|||||
2014
Q2 | $34.9M | Buy |
|
|||||
2014
Q1 | $36.9M | Sell |
|
|||||
2013
Q4 | $35.3M | Buy |
|
|||||
2013
Q3 | $33M | Sell |
|
|||||
2013
Q2 | $32.4M | Buy |
|